Ayurveda-based wellness and vitamin model Kapiva closed FY25 with sturdy income development, at the same time as greater spending on promoting and operations continued to affect profitability.

The direct-to-consumer (D2C) startup recorded income from operations of Rs 342 crore for the monetary yr ended March 31, 2025, marking a 50% enhance from Rs 228 crore in FY24.

With non-operating revenue of round Rs 7 crore, Kapiva’s whole revenue stood at almost Rs 349 crore in the course of the yr.

Product gross sales remained the one income, supported by wider distribution throughout on-line platforms and marketplaces and rising shopper curiosity in preventive well being options.

FY25 noticed a pointy rise in marketing-led expenditure. Promoting and promotional spending elevated 53% year-on-year to Rs 188 crore, making it the corporate’s largest expense head and accounting for about 45% of whole prices.

Total bills rose 44% to Rs 418 crore in FY25, in comparison with Rs 290 crore in FY24. Price of supplies consumed elevated 43% to Rs 97 crore, contributing roughly 23% of whole bills. Worker profit prices grew 28% to Rs 59 crore, whereas transportation and logistics bills stood at Rs 22 crore. Authorized {and professional} costs doubled to Rs 16 crore, including additional strain on prices.

Consequently, Kapiva’s internet loss widened to Rs 69 crore in FY25, in comparison with Rs 56 crore in FY24.

Based in 2015, Kapiva operates within the Ayurvedic and plant-based vitamin area. The corporate focuses on way of life and wellness classes comparable to diabetes administration, thyroid and hormonal well being, liver care, digestion, immunity, vitality, and sports activities vitamin.